Vaginal Candidiasis. Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere
Conditions
Interventions
Intervention 1: The control group: The 55 subjects in this group will be treated by Clogine suppository containing 1% clotrimazole, one suppository for 7 nights. The participants will complete the d
including 1) checklist of symptoms of vaginal candidiasis and 2) Checklist of signs of vaginal candiasis
will be completed twice, first: with initiating of treatment and second: 7 days following treatment completion. Also, they will complete the form for assessing the side efects of the medications afte
Sponsors
Tabib Daru Dez.
Eligibility
Sex/Gender
Female
Age
18 Years to 44 Years
Inclusion criteria
Inclusion criteria: Married women aged between 18 to 44 years Old non- pregnant, non-breastfeeding, non- menopaused No vaginal bleeding Not taking any vaginal cream or suppository medications during the previous 48 hours not taking any antibiotics or antifungal medications for vaginitis during the previous 2 weeks not taking any corticostroids during the previous 2 weeks Patient with vaginal candidiasis No history of chronic diseases
Exclusion criteria
Exclusion criteria: Existance of other vaginal infections Pregnancy during the study period Participation in another trial Occurrence of side effects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of vaginal candidiasis (including: pruritus, vaginal soreness, dyspareunia, external dysuria, and abnormal vaginal discharge). Timepoint: Before intervention and 7 days after intervention. Method of measurement: Completing the checklist to assess the symptoms vaginal candidiasis and then comparing the frequency of the Symptoms of vaginal candidiasis within and between two groups of treatment.;2) Signs of vaginal candiasis (Including; vaginal erythema, excoriations, thick white adherent discharge). Timepoint: Before intervention and 7 days after intervention. Method of measurement: Completing the checklist to assess the Signs of Vaginal Candidiasis following vaginal examination and observation. Then comparing the frequency of the signs of vaginal candidiasis within and between two groups of treatment.;The possible side defects of the medications after treatment. Timepoint: Before intervention and 7 days after intervention. Method of measurement: Completing the checklist to assess the possible side effects of the medications and then comparing the frequency of the side effects within and between two groups of treatment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohaddese Mahboubi
Tabibdaru
Outcome results
None listed